BEAUMONT, Texas — A Beaumont nonprofit that has helped families across Southeast Texas achieve homeownership for more than a decade is scaling back services in the city after losing local funding, ...
We're monitoring the cut line at the 2026 Houston Open to see which PGA Tour golfers are in line to make or miss the cut. Brooks Koepka, making his sixth start since returning from LIV Golf, got off ...
The Players Championship at TPC Sawgrass is one of the most coveted titles of the entire PGA Tour season, but the battle for that trophy can wait for the weekend. After all, the cut line was under the ...
PONTE VEDRA BEACH — The Players Championship almost lost the No. 1 player in the world for the weekend, but Scottie Scheffler was able to finish his final two holes in 1-under to make the cut with one ...
GameSpot may get a commission from retail offers. Sucker Punch Productions’ Ghost of Yotei is already an ambitious open-world adventure that builds on its predecessor in several ways, but the team had ...
Sheldon Isaac trimmed his list to seven schools this week, and Mississippi State is sitting in a spot that should keep the Bulldogs very much in the thick of things as spring rolls on. The McComb ...
Novo Nordisk NOVO.B1.16%increase; green up pointing triangle plans to slash U.S. list prices for its popular weight-loss and diabetes drugs Wegovy and Ozempic by up to half starting next year. Under ...
Novo Nordisk on Tuesday announced plans to cut the list price of its popular diabetes and weight-loss drugs Ozempic and Wegovy by as much as 50% in the U.S. next year. The Danish drugmaker indicated ...
Novo Nordisk on Tuesday said it plans to slash the monthly list prices of its popular obesity and diabetes drugs in the U.S. by up to 50% starting in 2027. The move aims to make the treatments more ...
Novo Nordisk will slash U.S. list prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 50% starting next year, the Danish drugmaker said on Tuesday. Subscribe to read ...
COPENHAGEN, Feb 24 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab said on Tuesday it plans to slash the U.S. list prices of its blockbuster weight-loss drug Wegovy and diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results